ADAP Price Targets and Analyst Ratings NASDAQ:ADAP
ADAP Forecast. What You Should Know.
ADAP Historical Ratings and Targets
About Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.